Glenmark Pharmaceuticals ... offsetting an equivalent amount of greenhouse gas emissions," the company said in a statement. NLCIL aims to achieve 10 GW of renewable energy capacity by 2030.

Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex. Nasdaq-listed GW is in line for $220 ...

In 2021, the company acquired GW Pharmaceuticals for $7.2bn, gaining the seizure medication Epidiolex (cannabidiol). In February 2024, it licensed a KRAS inhibitor programme from UK-based Redx ...

It plays a crucial role in reducing greenhouse gas emissions ... highlights that global installed capacity reached 495 GW in 2024, marking a 14% increase from the previous year.

Global offshore wind is gearing up for a comeback in 2025, with new capacity additions expected to hit 19 gigawatts (GW) and spending projected to soar to $80 billion, according to Oslo-based ...

A backlog of delayed projects led to a record 148.1% surge in 2023, raising new capacity to 216.88 GW. Despite this, 2024 saw further growth, with installations up 28.3% to 277.57 GW, pushing ...

WASHINGTON, March 24 (Reuters) - U.S. President Donald Trump said on Monday he will in the very near future announce tariffs on automobiles, aluminum and pharmaceuticals. Speaking to reporters at ...

GW Pharmaceuticals ended 2017 by filing its childhood epilepsy drug Epidiolex with regulators in the US and EU, setting up a potential launch for a drug that could transform the company's fortunes.

though administrators labeled one protest of the Israel-Hamas conflict as an “illegal and potentially dangerous occupation of GW property.” The university claimed that demonstration included ...

A greenhouse is a major investment for your garden and one that’s not easy to move or replace once installed, so it's important to pick the right one for your needs. Whether you're shopping for a ...